Skip to main content

49 publications

Name Date Type Actions

Monthly information regarding the total number of voting rights and shares making of the share capital - February 2020

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Voting rights

Vetoquinol to acquire rights for Profender® and Drontal® from Elanco Animal Health for the European economic area and the UK

February 12 th , 2020 (Lure, France) - Vetoquinol has agreed terms to acquire the European Economic area and UK rights to Profender® and Drontal® product families from Elanco Animal Health.

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - January 2020

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Voting rights

2019 sales: €396.0 million (Up 7.6%)

The Vetoquinol Group posted 2019 sales of €396.0 million, up 7.6% as reported and up 6.1% at constant exchange rates.

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - December 2019

Voting rights

Matthieu Frechin named Managing Director of Vétoquinol

December 14, 2009 (Lure, France) – The Board of Directors of Vétoquinol, at its December 10
meeting, has named Matthieu Frechin Managing Director of the Vétoquinol Group, replacing
Etienne Frechin. He will be seconded by Dominique Henryon, Deputy General Manager.
Etienne Frechin will give up all operating functions but will continue to serve as Chairman of
Vétoquinol’s Board of Directors.

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Voting rights

Strong growth in Revenues in the 3rd quarter

Vétoquinol recorded strong growth in the 3rd quarter of 2009, despite an unfavourable exchange rate effect. The strength in sales was due to a combination of the contribution of acquisitions in Italy and India and sustained organic growth.

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Voting rights